Quarterly report [Sections 13 or 15(d)]

Condensed Balance Sheets

v3.26.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 8,923,000 $ 6,811,000
Restricted cash 94,000 94,000
Deferred offering costs 570,000 634,000
Prepaid expenses and other current assets 409,000 567,000
TOTAL ASSETS 9,996,000 8,106,000
Current liabilities    
Accounts payable 253,000 748,000
Accrued expenses 2,163,000 1,560,000
Warrant liability 11,000
Total Current Liabilities 2,416,000 2,319,000
Stockholders’ Equity    
Preferred stock value 1,000 1,000
Common stock, par value $0.001, 250,000,000 shares authorized, 35,181,891 and 25,534,173 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively 35,000 26,000
Additional paid in capital 734,381,000 729,661,000
Accumulated deficit (726,837,000) (723,901,000)
Total Stockholders’ Equity 7,580,000 5,787,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 9,996,000 8,106,000
Series L Preferred Stock [Member]    
Stockholders’ Equity    
Preferred stock value